Technical Data
L1397-85B
LATS2 (Large Tumor Suppressor Homolog 2, LATS-2, FLJ13161, Kinase Phosphorylated During Mitosis Protein, KPM, Serine/threonine-protein Kinase LATS2, Serine/threonine-protein Kinase kpm, Warts-like Kinase)
Description:
LATS2 is a serine/threonine protein kinase belonging to the LATS tumor suppressor family. This protein localizes to centrosomes during interphase, and early and late metaphase. It interacts with the centrosomal proteins aurora-A and ajuba and is required for accumulation of gamma-tubulin and spindle formation at the onset of mitosis. It also interacts with a negative regulator of p53 and may function in a positive feedback loop with p53 that responds to cytoskeleton damage. Additionally, it can function as a co-repressor of androgen-responsive gene expression.

Applications:
Suitable for use in ELISA, Western Blot, and Immunohistochemistry. Other applications not tested.

Recommended Dilution:
ELISA: 1:1,000
Western Blot: 1:100-1:500
Immunohistochemistry: 1:10-1:50
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
PabIgGAffinity Purified
SizeStorageShippingSourceHost
200ul-20CBlue IceHumanRabbit
Concentration:
As reported
Immunogen:
Synthetic peptide selected from the center region of human LATS2 (KLH).
Purity:
Purified by Protein G affinity chromatography.
Form
Supplied as a liquid in PBS, 0.09% sodium azide.
Specificity:
Recognizes human LATS2. Species Crossreactivity: mouse.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1.Blume-Jensen P, et al. Nature 2001. 411: 355. 2.Cantrell D, J. Cell Sci. 2001. 114: 1439. 3.Jhiang S Oncogene 2000. 19: 5590. 4.Manning G, et al. Science 2002. 298: 1912. 5.Moller, D, et al. Am. J. Physiol. 1994. 266: C351-C359. 6.Robertson, S. et al. Trends Genet. 2000. 16: 368. 7.Robinson D, et al. Oncogene 2000. 19: 5548. 8.Van der Ven, P, et al. Hum. Molec. Genet. 1993. 2: 1889. 9.Vanhaesebroeck, B, et al. Biochem. J. 2000. 346: 561. 10.Van Weering D, et al. Recent Results Cancer Res. 1998. 154: 271.